“Out of over a million persons given the Oxford-AstraZeneca COVID-19 vaccine in Nigeria, 8,439 persons have suffered mild Adverse Events Following Immunisation (AEFI), and 52 persons moderate to severe adverse events on receiving the jab. Shuaib restated that there was currently a global shortfall of COVID-19 vaccines, forcing the federal government to reassess vaccine supply forecasts. It noted that the vaccine roll-out would be in four phases, starting with health workers, frontline workers, COVID-19 rapid response team, laboratory network, policemen, petrol station workers and strategic leaders. On April 6, the government of India also delivered 100,000 doses of Covishield COVID-19 vaccines to Nigeria. With only about 4.4 million doses of COVID-19 vaccines available in the country, Nigeria is still far from reaching its set target, according to health experts.

Source: The Guardian April 16, 2021 15:22 UTC